Go to:
Projects
More content Highly sensitive detection methods for clinically relevant protein biomarkers : Date: 04.10.2011 GO-Bio 4 – Dr. Thole Züchner – Centre for Biotechnology and Biomedicine (BBZ), University of Leipzig Continue reading Hearing the light from the body – the next generation of imaging : Date: 04.10.2009 GO-Bio 3 – Prof. Vasilis Ntziachristos, Christian Wiest – Institute for Biological and Medical Imaging (IBMI), Helmholtz Center Munich | iThera Medical GmbH Continue reading New therapies on the basis of RNA molecules : Date: 04.10.2009 GO-Bio 3 – Prof. Dr. Gunther Hartmann – Institute of Clinical Chemistry and Pharmacology, University Hospital Bonn Continue reading Using biochips to analyse cell networks and test active substances : Date: 04.10.2009 GO-Bio 3 – Philipp Julian Köster – Department of Biophysics, University of Rostock Continue reading Genetic vaccines: New platform technology for improved efficacy : Date: 04.10.2009 GO-Bio 3 – Dr. Florian Kreppel – Department of Gene Therapy, University of Ulm Continue reading Multi-organ bioreactor in chip format : Date: 04.10.2009 GO-Bio 3 – Prof. Roland Lauster, Dr. Uwe Marx – Chair of Medical Biotechnology, Technical University Berlin | TissUse GmbH Continue reading Immunotherapy to combat the hospital bug Staphylococcus aureus : Date: 04.10.2009 GO-Bio 3 – PD Dr. Knut Ohlsen – Institute for Molecular Infection Biology (IMIB), University of Würzburg Continue reading Tracking down the security guards of the cell: New therapeutic approach for the treatment of cardiovascular diseases : Date: 04.10.2007 GO-Bio 2 – PD Dr. Enno Klußmann – Forschungsverbund Berlin e. V. Continue reading Development of a blood purification method for the treatment of patients with acute myocardial infarction : Date: 04.10.2007 GO-Bio 2 – Dr. Ahmed Sheriff – Charité University Medicine Berlin, Clinic of Nephrology and Internal Intensive Care Medicine, as well as the Clinic of Cardiology, Campus Virchow Klinikum Continue reading Production of small RNA molecules for muting long non-coding RNAs : Date: 04.10.2007 GO-Bio 2 – Prof. Dr. Frank Buchholz – Dresden University Hospital | Eupheria Biotech GmbH Continue reading Molecular scissors for tackling HIV : Date: 04.10.2007 GO-Bio 2 – Prof. Dr. Joachim Hauber – Department of Cell Biology and Virology, Heinrich Pette Institute (HPI) for Experimental Virology and Immunology, Hamburg Continue reading Development of a new class of drug for the prevention of organ damage in cardiac insufficiency and diabetes : Date: 04.10.2007 GO-Bio 2 – Dr. Heiko Funke-Kaiser – Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charité University Medicine Berlin Continue reading Equipping potatoes with resistance to fungal infestation : Date: 04.10.2007 GO-Bio 2 – Dr. Dieter Peschen – Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Aachen Continue reading Development of more effective antibodies against leukaemia and solid tumours : Date: 04.10.2007 GO-Bio 2 – Dr. Ludger Große-Hovest, Gundram Jung – Center for Clinical Transfusion Medicine (ZKT), Tübingen; Synimmune GmbH Continue reading New active substances for activating or inhibiting AGC protein kinases : Date: 04.10.2007 GO-Bio 2 – Dr. Ricardo M. Biondi – Goethe University Frankfurt Continue reading A biocatalysis reactor for the industrial-scale production of therapeutic siRNA molecules : Date: 04.10.2007 GO-Bio 2 – PD Dr. med. Jacques Rohayem – Technical University Dresden | Riboxx GmbH, Radebeul Continue reading Neuroprosthesis for the restoration of mobility in people with severe paralysis : Date: 01.10.2007 GO-Bio 1 – Dr. Carsten Mehring – ‘Computational Motor Control & Brain-Machine Interfaces’ working group, Albert Ludwig University of Freiburg Continue reading Development of cancer drugs on the basis of highly effective small molecules : Date: 10.10.2006 GO-Bio 1 – Joe Lewis, PhD – European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) at the Helmholtz Association, Heidelberg | Elara Pharmaceuticals GmbH Continue reading Development of cancer drugs using combined methods of genome and drug screening : Date: 04.10.2006 GO-Bio 1 – Dr. Michael Boutros – German Cancer Research Center (DKFZ), Helmholtz Association, Heidelberg Continue reading New means of isolating cells and particles for medicine and biotechnology : Date: 04.10.2006 GO-Bio 1 – Dr. Jan-Michael Heinrich – cliMECS GmbH (now pluriSelect) in Leipzig Continue reading Search results 61 to 80 from a total of 85 1 - 20 21 - 40 41 - 60 61 - 80 81 - 85
More content
GO-Bio 4 – Dr. Thole Züchner – Centre for Biotechnology and Biomedicine (BBZ), University of Leipzig
Continue reading
GO-Bio 3 – Prof. Vasilis Ntziachristos, Christian Wiest – Institute for Biological and Medical Imaging (IBMI), Helmholtz Center Munich | iThera Medical GmbH
GO-Bio 3 – Prof. Dr. Gunther Hartmann – Institute of Clinical Chemistry and Pharmacology, University Hospital Bonn
GO-Bio 3 – Philipp Julian Köster – Department of Biophysics, University of Rostock
GO-Bio 3 – Dr. Florian Kreppel – Department of Gene Therapy, University of Ulm
GO-Bio 3 – Prof. Roland Lauster, Dr. Uwe Marx – Chair of Medical Biotechnology, Technical University Berlin | TissUse GmbH
GO-Bio 3 – PD Dr. Knut Ohlsen – Institute for Molecular Infection Biology (IMIB), University of Würzburg
GO-Bio 2 – PD Dr. Enno Klußmann – Forschungsverbund Berlin e. V.
GO-Bio 2 – Dr. Ahmed Sheriff – Charité University Medicine Berlin, Clinic of Nephrology and Internal Intensive Care Medicine, as well as the Clinic of Cardiology, Campus Virchow Klinikum
GO-Bio 2 – Prof. Dr. Frank Buchholz – Dresden University Hospital | Eupheria Biotech GmbH
GO-Bio 2 – Prof. Dr. Joachim Hauber – Department of Cell Biology and Virology, Heinrich Pette Institute (HPI) for Experimental Virology and Immunology, Hamburg
GO-Bio 2 – Dr. Heiko Funke-Kaiser – Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charité University Medicine Berlin
GO-Bio 2 – Dr. Dieter Peschen – Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Aachen
GO-Bio 2 – Dr. Ludger Große-Hovest, Gundram Jung – Center for Clinical Transfusion Medicine (ZKT), Tübingen; Synimmune GmbH
GO-Bio 2 – Dr. Ricardo M. Biondi – Goethe University Frankfurt
GO-Bio 2 – PD Dr. med. Jacques Rohayem – Technical University Dresden | Riboxx GmbH, Radebeul
GO-Bio 1 – Dr. Carsten Mehring – ‘Computational Motor Control & Brain-Machine Interfaces’ working group, Albert Ludwig University of Freiburg
GO-Bio 1 – Joe Lewis, PhD – European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) at the Helmholtz Association, Heidelberg | Elara Pharmaceuticals GmbH
GO-Bio 1 – Dr. Michael Boutros – German Cancer Research Center (DKFZ), Helmholtz Association, Heidelberg
GO-Bio 1 – Dr. Jan-Michael Heinrich – cliMECS GmbH (now pluriSelect) in Leipzig
Search results 61 to 80 from a total of 85